Pharma & Biotech

The investment case for Danish pharmaceutical giant Novo Nordisk appears to be in tatters as 2025 unfolds, with its equity...

BioNxt Solutions has achieved a critical milestone in its commercial strategy, strengthening both its market position and intellectual property portfolio....

Viking Therapeutics has successfully completed patient enrollment for its pivotal VANQUISH-1 Phase 3 clinical trial ahead of schedule, marking a...

Redcare Pharmacy shares are experiencing a severe downturn, with the stock price collapsing to unprecedented levels. The online pharmacy operator...

Novavax finds itself in a critical battle for corporate survival. The biotech firm's stock is attempting to stabilize following a...

The exclusive trillion-dollar valuation club, long dominated by technology behemoths like Apple and Microsoft, has welcomed an unexpected new member....

Biotechnology firm Moderna is navigating one of the most challenging periods in its corporate history, implementing sweeping changes to secure...

The countdown has begun for CureVac's final days as an independent publicly traded company. A special shareholder meeting scheduled for...

A curious divergence is unfolding for Valneva's stock. While the biotech firm demonstrates significant operational improvements and dramatically curtails its...

Eli Lilly has become the first pharmaceutical company globally to surpass a $1 trillion market valuation, marking an unprecedented milestone...